Ohyanagi, H

A new monoclonal-antibody-defined tumor marker (KMO1) for pancreatic carcinoma. [electronic resource] - The Mount Sinai journal of medicine, New York Jun 1987 - 393-400 p. digital

Publication Type: Comparative Study; Journal Article

0027-2507


Antibodies, Monoclonal
Biomarkers, Tumor--analysis
Cell Line
Hemagglutination Tests--methods
Immunohistochemistry
Pancreatic Neoplasms--immunology